DERM Journey Medical Corp
Price (delayed)
$6.24
Market cap
$144.17M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.72
Enterprise value
$149.57M
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated
Highlights
The equity has surged by 84% since the previous quarter
DERM's EPS is up by 23% since the previous quarter
The debt is up by 45% YoY and by 22% QoQ
The company's gross profit fell by 37% YoY and by 4.4% QoQ
Key stats
What are the main financial stats of DERM
Market
Valuations
Earnings
Shares outstanding
23.1M
Market cap
$144.17M
Enterprise value
$149.57M
Price to earnings (P/E)
N/A
Price to book (P/B)
6.5
Price to sales (P/S)
2.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.66
Revenue
$56.13M
Gross profit
$35.26M
Operating income
-$13.68M
Net income
-$14.67M
EBIT
-$11.91M
EBITDA
-$8.4M
Free cash flow
-$9.13M
Per share
Balance sheet
Liquidity
EPS
-$0.72
EPS diluted
-$0.72
Free cash flow per share
-$0.45
Book value per share
$0.96
Revenue per share
$2.75
TBVPS
$2.37
Total assets
$80.24M
Total liabilities
$60.17M
Debt
$25.71M
Equity
$20.07M
Working capital
$13M
Debt to equity
1.28
Current ratio
1.37
Quick ratio
0.87
Net debt/EBITDA
-0.64
Margins
Efficiency
Dividend
EBITDA margin
-15%
Gross margin
62.8%
Net margin
-26.1%
Operating margin
-24.4%
Return on assets
-21.3%
Return on equity
-106.2%
Return on invested capital
-110.2%
Return on capital employed
-26.4%
Return on sales
-21.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
DERM stock price
How has the Journey Medical stock price performed over time
Intraday
4.52%
1 week
1.63%
1 month
10.83%
1 year
83.53%
YTD
59.59%
QTD
5.76%
Financial performance
How have Journey Medical's revenue and profit performed over time
Revenue
$56.13M
Gross profit
$35.26M
Operating income
-$13.68M
Net income
-$14.67M
Gross margin
62.8%
Net margin
-26.1%
The company's gross profit fell by 37% YoY and by 4.4% QoQ
The revenue is down by 29% year-on-year and by 2.8% since the previous quarter
Journey Medical's operating income has increased by 24% QoQ
DERM's operating margin is up by 22% QoQ
Growth
What is Journey Medical's growth rate over time
Valuation
What is Journey Medical stock price valuation
P/E
N/A
P/B
6.5
P/S
2.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.66
DERM's EPS is up by 23% since the previous quarter
The equity has surged by 84% since the previous quarter
DERM's price to book (P/B) is 18% lower than its last 4 quarters average of 7.6
DERM's price to sales (P/S) is 55% higher than its last 4 quarters average of 1.4
The revenue is down by 29% year-on-year and by 2.8% since the previous quarter
Efficiency
How efficient is Journey Medical business performance
The ROIC has soared by 50% QoQ
DERM's return on sales is up by 25% since the previous quarter
Journey Medical's return on assets has increased by 21% QoQ
DERM's ROE is up by 20% QoQ
Dividends
What is DERM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for DERM.
Financial health
How did Journey Medical financials performed over time
The company's total assets is 33% higher than its total liabilities
The company's total assets rose by 25% QoQ and by 4.4% YoY
The company's quick ratio fell by 15% YoY and by 12% QoQ
The debt is 28% higher than the equity
The equity has surged by 84% since the previous quarter
DERM's debt to equity is up by 47% year-on-year but it is down by 34% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.